Search Results - "Hartley, Cynthia"

Refine Results
  1. 1

    Radioprotection of Mice by Recombinant Rat Stem Cell Factor by Zsebo, Krisztina M., Smith, Kent A., Hartley, Cynthia A., Greenblatt, Melvin, Cooke, Keegan, Rich, William, McNiece, Ian K.

    “…Treatment with recombinant rat stem cell factor (rSCF) protects mice from the lethal effects of irradiation. Mice treated with a single dose of rSCF prior to…”
    Get full text
    Journal Article
  2. 2

    Comparison of epoetin alfa and darbepoetin alfa biological activity under different administration schedules in normal mice by Sasu, Barbra J, Hartley, Cynthia, Schultz, Henry, McElroy, Patricia, Khaja, Raheemuddin, Elliott, Steven, Egrie, Joan C, Browne, Jeffrey K, Begley, C Glenn, Molineux, Graham

    Published in Acta haematologica (01-01-2005)
    “…The unit of erythropoietic activity has long been the standard by which erythropoietic agents are judged, but the development of long-acting agents such as…”
    Get more information
    Journal Article
  3. 3

    Most purported antibodies to the human granulocyte colony-stimulating factor receptor are not specific by deBruin, Cortney, Lincoln, Patrice, Hartley, Cynthia, Shehabeldin, Amro, Van, Gwyneth, Szilvassy, Stephen J

    Published in Experimental hematology (01-11-2010)
    “…Objective Antibodies to human granulocyte colony-stimulating factor receptor (HuG-CSFR) are widely available and have been used in numerous studies to evaluate…”
    Get full text
    Journal Article
  4. 4

    Fetal Hemoglobin Expression Is Differentially Affected by Inhibition of the Proposed Dred Complex Constituents, LSD1 and DNMT1 by Arvedson, Tara L, Tran, Lynn, Ross, Sandra L, Yoder, Sean, Hertz, Alexandra, Hale, Kari, Eschelbach, John, Dineen, Tom, Matyas, Stephanie, Hartley, Cynthia, Morgenstern, Kurt, Winters, Dwight, Cindy, Park, Molineux, Graham, Coxon, Angela

    Published in Blood (16-11-2012)
    “…Abstract 3263 Sickle cell disease and beta thalassemia are disorders caused by mutations in adult hemoglobin (HbA) or defects in HbA expression. A potential…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemia by SHOUCHENG NING, HARTLEY, Cynthia, MOLINEUX, Graham, KNOX, Susan J

    Published in Cancer research (Chicago, Ill.) (2005)
    “…Darbepoietin alfa (DA) is a long-acting analogue of erythropoietin that has reduced receptor affinity and enhanced biological activity. Experiments were done…”
    Get full text
    Journal Article
  7. 7

    New Longer Acting Erythropoiesis Stimulating Proteins (ESPs) Correct Anemia with a Less Frequent Dosing Schedule in a Mouse Model by Hartley, Cynthia A., McElroy, Patricia, Khaja, Raheem, Molineux, Graham

    Published in Blood (16-11-2004)
    “…Introduction: Recombinant human erythropoietin (rHuEPO) has become a standard treatment for the alleviation of anemia resulting from chronic renal failure and…”
    Get full text
    Journal Article
  8. 8

    Darbepoetin alfa Radiosensitizes Tumors Independent of Anemia or the Correction of Anemia by Ning, Shoucheng, Angus, Sinclair, Cynthia, Hartley, Susan, Knox

    Published in Blood (16-11-2004)
    “…Darbepoetin alfa (DA) is a FDA approved long acting erythropoietic protein. We hypothesized that correction of anemia in tumor-bearing mice by DA would…”
    Get full text
    Journal Article
  9. 9

    Chronic Exposure to Retroviral Vector Encoded MGDF (mpl-Ligand) Induces Lineage-Specific Growth and Differentiation of Megakaryocytes in Mice by Yan, Xiao-Qiang, Lacey, David, Fletcher, Frederick, Hartley, Cynthia, McElroy, Patricia, Sun, Yu, Xia, Min, Mu, Sharon, Saris, Chris, Hill, David, Hawley, Robert G., McNiece, Ian K.

    Published in Blood (01-12-1995)
    “…Megakaryocyte growth and development factor (MGDF) has recently been identified as a ligand for the c-mpl receptor. Using retroviral-mediated gene transfer,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients by Molineux, G, Hartley, C, McElroy, P, McCrea, C, McNiece, IK

    Published in Blood (01-07-1996)
    “…We have investigated the potential of PEGylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF), a molecule related to…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation by MOLINEUX, G, HARTLEY, C. A, MCELROY, P, MCREA, C, MCNIECE, I. K

    Published in Blood (15-08-1996)
    “…Megakaryocyte growth and development factor (MGDF) is a recently characterized ligand for the cell surface receptor mpl. We have evaluated the effects of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    PEG-rHuMGDF promotes multilineage hematopoietic recovery in myelosuppressed mice by Ulich, Thomas R, del Castillo, Juan, Senaldi, Giorgio, Hartley, Cynthia, Molineux, Graham

    Published in Experimental hematology (01-12-1999)
    “…PEG-rHuMGDF administered to normal mice is a lineage-specific growth factor for megakaryocytes and platelets as judged by morphologic examination of…”
    Get full text
    Journal Article
  16. 16

    Chronic expression of murine flt3 ligand in mice results in increased circulating white blood cell levels and abnormal cellular infiltrates associated with splenic fibrosis by JUAN, T. S.-C, MCNIECE, I. K, FLETCHER, F. A, VAN, G, LACEY, D, HARTLEY, C, MCELROY, P, SUR, Y, ARGENTO, J, HILL, D, YAN, X.-Q

    Published in Blood (01-07-1997)
    “…The effect of chronic expression of flt3 ligand (FL) on in vivo hematopoiesis was studied. Retroviral vector-mediated gene transfer was used in a mouse model…”
    Get full text
    Journal Article
  17. 17

    Prolonged neutropenia in a novel mouse granulocyte colony-stimulating factor neutralizing auto-immunoglobulin G mouse model by Coccia, Marco A., Hartley, Cynthia, Sutherland, Weston, Del Castillo, Juan, McElroy, Patricia, Pistillo, Jeanne, Tarpley, John E., Molineux, Graham

    Published in Experimental hematology (2001)
    “…Therapeutic use of recombinant human cytokines in humans can result in the generation of drug-specific antibodies. To predetermine the maximum potential…”
    Get full text
    Journal Article
  18. 18

    An Analysis of the Effects of Combined Treatment with rmGM‐CSF and PEG‐rHuMGDF in Murine Bone Marrow Transplant Recipients by Molineux, Graham, Hartley, Cynthia, McElroy, Patricia, McCrea, Clay, Kerzic, Patrick, McNiece, Ian

    Published in Stem cells (Dayton, Ohio) (01-01-1997)
    “…We have studied the potential of combination growth factor treatment with GM‐CSF and megakaryocyte growth and development factor (MGDF) to stimulate…”
    Get full text
    Journal Article
  19. 19

    Chronic Expression of Murine flt3 Ligand in Mice Results in Increased Circulating White Blood Cell Levels and Abnormal Cellular Infiltrates Associated With Splenic Fibrosis by Juan, Todd S.-C., McNiece, Ian K., Van, Gwenneth, Lacey, David, Hartley, Cynthia, McElroy, Patricia, Sun, Yu, Argento, Julie, Hill, David, Yan, Xiao-Qiang, Fletcher, Frederick A.

    Published in Blood (01-07-1997)
    “…The effect of chronic expression of flt3 ligand (FL) on in vivo hematopoiesis was studied. Retroviral vector-mediated gene transfer was used in a mouse model…”
    Get full text
    Journal Article
  20. 20

    The role of stem cell factor in mobilization of peripheral blood progenitor cells: synergy with G-CSF by McNiece, I K, Briddell, R A, Hartley, C A, Andrews, R G

    Published in Stem cells (Dayton, Ohio) (01-10-1993)
    “…The use of cytokine mobilized peripheral blood progenitor cells (PBPC) in transplantation following chemotherapy has led to enhanced engraftment…”
    Get more information
    Journal Article